Skip to main content
. 2015 Jun 16;2015:181986. doi: 10.1155/2015/181986

Table 1.

Characteristics of study subjects.

PS
Number of patients 43
Male (%) 58.00
Mean age 39
DLCO (mean ± SD) 69.5 ± 15.7
Chest X-ray stage, (PS, stage I/II/III/IV) 8/30/3/2
>20% Lymphocytes in BALF (% patients) 73%
CD4/CD8 >3,5 (% patients) 67%
Lymphadenopathy (% patients) 88%
Granuloma proven (biopsy) 28%

PS: pulmonary sarcoidosis; DLCO: percentage of predicted carbon monoxide lung diffusion capacity.